High levels of AKT and phospho-AKT have been detected in the majority of GBM tumor samples and cell lines, where it supports uncontrolled glioma cells growth, apoptotic blockage, and tumor invasion, thus representing an attractive pathway for GBM targeting therapy [37]. Here, AKT1 is linked to central nervous system cancer.